-
1
-
-
0037639971
-
The current status of hematopoietic cell transplantation
-
Appelbaum FR. The current status of hematopoietic cell transplantation. Annu Rev Med. 2003;54:491-512.
-
(2003)
Annu Rev Med
, vol.54
, pp. 491-512
-
-
Appelbaum, F.R.1
-
2
-
-
1942469964
-
The pathobiology of mucositis
-
Sonis ST. The pathobiology of mucositis. Nat Rev Cancer. 2004;4:277-284.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 277-284
-
-
Sonis, S.T.1
-
3
-
-
0027689181
-
Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation
-
McGuire DB, Altomonte V, Peterson DE, et al. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum. 1993;20:1493-1502.
-
(1993)
Oncol Nurs Forum
, vol.20
, pp. 1493-1502
-
-
McGuire, D.B.1
Altomonte, V.2
Peterson, D.E.3
-
4
-
-
0033836189
-
Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue
-
Wardley AM, Jayson GC, Swindell R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol. 2000;110:292-299.
-
(2000)
Br J Haematol
, vol.110
, pp. 292-299
-
-
Wardley, A.M.1
Jayson, G.C.2
Swindell, R.3
-
5
-
-
0027275165
-
A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients
-
Woo SB, Sonis ST, Monopoli MM, Sonis AL. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer. 1993;72:1612-1617.
-
(1993)
Cancer
, vol.72
, pp. 1612-1617
-
-
Woo, S.B.1
Sonis, S.T.2
Monopoli, M.M.3
Sonis, A.L.4
-
6
-
-
0026639537
-
Relationships between oral mucositis and treatment variables in bone marrow transplant patients
-
Zerbe MB, Parkerson SG, Ortlieb ML, Spitzer T. Relationships between oral mucositis and treatment variables in bone marrow transplant patients. Cancer Nurs. 1992;15:196-205.
-
(1992)
Cancer Nurs
, vol.15
, pp. 196-205
-
-
Zerbe, M.B.1
Parkerson, S.G.2
Ortlieb, M.L.3
Spitzer, T.4
-
7
-
-
0141787012
-
The burdens of cancer therapy: Clinical and economic outcomes of chemotherapy-induced mucositis
-
Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 2003;98:1531-1539.
-
(2003)
Cancer
, vol.98
, pp. 1531-1539
-
-
Elting, L.S.1
Cooksley, C.2
Chambers, M.3
Cantor, S.B.4
Manzullo, E.5
Rubenstein, E.B.6
-
9
-
-
0031944107
-
Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity
-
Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998;34:39-43.
-
(1998)
Oral Oncol
, vol.34
, pp. 39-43
-
-
Sonis, S.T.1
-
10
-
-
0033952344
-
Patient reports of complications of bone marrow transplantation
-
Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer. 2000;8:33-39.
-
(2000)
Support Care Cancer
, vol.8
, pp. 33-39
-
-
Bellm, L.A.1
Epstein, J.B.2
Rose-Ped, A.3
Martin, P.4
Fuchs, H.J.5
-
11
-
-
0027997228
-
Stomatitis in the bone marrow transplant patient: An overview and proposed oral care protocol
-
Armstrong TS. Stomatitis in the bone marrow transplant patient: an overview and proposed oral care protocol. Cancer Nurs. 1994;17:403-410.
-
(1994)
Cancer Nurs
, vol.17
, pp. 403-410
-
-
Armstrong, T.S.1
-
12
-
-
10344242939
-
Palifermin for oral mucositis after intensive therapy for hematologic cancers
-
Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004;351:2590-2598.
-
(2004)
N Engl J Med
, vol.351
, pp. 2590-2598
-
-
Spielberger, R.1
Stiff, P.2
Bensinger, W.3
-
14
-
-
0038434492
-
Pharmacokinetics of anakinra in subjects with different levels of renal function
-
Yang B-B, Baughman S, Sullivan JT. Pharmacokinetics of anakinra in subjects with different levels of renal function. Clin Pharmacol Ther. 2003;74:85-94.
-
(2003)
Clin Pharmacol Ther
, vol.74
, pp. 85-94
-
-
Yang, B.-B.1
Baughman, S.2
Sullivan, J.T.3
-
15
-
-
0016916438
-
Prediction of creatinine clearance from serum creatinine
-
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
-
(1976)
Nephron
, vol.16
, pp. 31-41
-
-
Cockcroft, D.W.1
Gault, M.H.2
-
16
-
-
0003556717
-
-
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, and Center for Biologics Evaluation and Research. Rockville, MD: US Department of Health and Human Services
-
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, and Center for Biologics Evaluation and Research. Guidance for Industry: Pharmacokinetics in Patients With Impaired Renal Function: Study Design, Data Analysis, and Impact on Dosing and Labeling. Rockville, MD: US Department of Health and Human Services; 1998.
-
(1998)
Guidance for Industry: Pharmacokinetics in Patients with Impaired Renal Function: Study Design, Data Analysis, and Impact on Dosing and Labeling
-
-
-
17
-
-
33744779624
-
Pharmacokinetics, Pharmacodynamics, and Safety Assessment of Palifermin (rHuKGF) in Healthy Volunteers
-
Zia-Amirhosseini P, Salfi M, Leese P, et al. Pharmacokinetics, Pharmacodynamics, and Safety Assessment of Palifermin (rHuKGF) in Healthy Volunteers. Clin Pharmacol Ther. 2006;79:558-569.
-
(2006)
Clin Pharmacol Ther
, vol.79
, pp. 558-569
-
-
Zia-Amirhosseini, P.1
Salfi, M.2
Leese, P.3
-
19
-
-
0027275566
-
Physiological parameters in laboratory animals and humans
-
Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res. 1993;10:1093-1095.
-
(1993)
Pharm Res
, vol.10
, pp. 1093-1095
-
-
Davies, B.1
Morris, T.2
-
20
-
-
0002272443
-
Enzymes
-
Tietz NW, ed. Philadelphia, Pa: WB Saunders Company
-
Moss DW, Henderson AR, Kachmar JF. Enzymes. In: Tietz NW, ed. Textbook of Clinical Chemistry. Philadelphia, Pa: WB Saunders Company; 1986:619-763.
-
(1986)
Textbook of Clinical Chemistry
, pp. 619-763
-
-
Moss, D.W.1
Henderson, A.R.2
Kachmar, J.F.3
-
21
-
-
0037842184
-
Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: Potential role as mucosal protectant
-
Meropol NJ, Somer RA, Gutheil J, et al. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant. J Clin Oncol. 2003;21:1452-1458.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1452-1458
-
-
Meropol, N.J.1
Somer, R.A.2
Gutheil, J.3
|